APA

Flotte T. R., Zeitlin P. L., Reynolds T. C., Heald A. E., Pedersen P., Beck S., Conrad C. K., Brass-Ernst L., Humphries M., Sullivan K., Wetzel R., Taylor G., Carter B. J. & Guggino W. B. (20030926). Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: a two-part clinical study. : Human gene therapy.

Chicago

Flotte Terence R, Zeitlin Pamela L, Reynolds Thomas C, Heald Alison E, Pedersen Patty, Beck Suzanne, Conrad Carol K, Brass-Ernst Lois, Humphries Margaret, Sullivan Kevin, Wetzel Randall, Taylor George, Carter Barrie J and Guggino William B. 20030926. Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: a two-part clinical study. : Human gene therapy.

Harvard

Flotte T. R., Zeitlin P. L., Reynolds T. C., Heald A. E., Pedersen P., Beck S., Conrad C. K., Brass-Ernst L., Humphries M., Sullivan K., Wetzel R., Taylor G., Carter B. J. and Guggino W. B. (20030926). Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: a two-part clinical study. : Human gene therapy.

MLA

Flotte Terence R, Zeitlin Pamela L, Reynolds Thomas C, Heald Alison E, Pedersen Patty, Beck Suzanne, Conrad Carol K, Brass-Ernst Lois, Humphries Margaret, Sullivan Kevin, Wetzel Randall, Taylor George, Carter Barrie J and Guggino William B. Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: a two-part clinical study. : Human gene therapy. 20030926.